D. Siri

AR101 Oral Immunotherapy for Peanut Allergy

William H. Yang, N. Rupp, G. Toit, 2018, The New England journal of medicine.

Distinguishing alpha1-antitrypsin deficiency from asthma.

H. Farah, D. Hogarth, D. Siri, 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Distinguishing alpha1-antitrypsin deficiency from asthma.

H. Farah, D. Hogarth, D. Siri, 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Towards an FDA-cleared basophil activation test

Douglas H. Jones, G. Marti, M. Rathkopf, 2023, Frontiers in Allergy.

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.

William H. Yang, N. Rupp, H. Sampson, 2021, The journal of allergy and clinical immunology. In practice.

Mepolizumab Reduces Exacerbations and Improves Health-Related Quality of Life in Patients With Severe Asthma and Nasal Polyps, Sinusitis, or Allergic Rhinitis

S. Yancey, S. Wenzel, N. Jain, 2020 .

Egg allergy and influenza vaccination.

J. Bellanti, R. Settipane, D. Siri, 2009, Allergy and asthma proceedings.

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.

H. Makita, W. Busse, E. Bleecker, 2019, The Lancet. Respiratory medicine.